James New

James New

Amministratore Delegato presso
Wavodyne Therapeutics, Inc.
72 anni
Health Technology
Consumer Services
Commercial Services

Profilo

James New is the founder of Wavodyne Therapeutics, Inc. Former positions include Chief Executive Officer at Abrika Pharmaceuticals LLP from 2002 to 2007, President & Chief Executive Officer at Veloxis Pharmaceuticals A from 2008 to 2009, Chief Executive Officer at AIKO Biotechnology, Inc., President & Chief Executive Officer at Synaptogenix, Inc. in 2014, Director at Neurotrope, Inc. in 2014, Principal at Bristol Myers Squibb Co. from 1980 to 1992, Principal at Pfizer Inc. from 1994 to 1999, Principal at Novartis AG from 1999 to 2001, and Principal at GSK Plc.
Education includes an undergraduate degree from State University of New York College at Geneseo, a doctorate from State University of New York at Buffalo, a graduate degree from the University of Maine, and an MBA from Columbia Business School.

Posizioni attive di James New

SocietàPosizioneInizio
Amministratore Delegato -

Precedenti posizioni note di James New

SocietàPosizioneFine
NEUROTROPE, INC. Amministratore Delegato 16/07/2014
SYNAPTOGENIX, INC. Amministratore Delegato 16/07/2014
VELOXIS PHARMACEUTICALS A/S Amministratore Delegato 01/01/2009
Amministratore Delegato 01/01/2007
NOVARTIS AG Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di James New

Formazione di James New

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

78

Relazioni di 1° grado

14

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private14

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Technology Services

Consumer Services

Health Technology